vs
ARDELYX, INC.（ARDX）与Rocket Lab Corp（RKLB）财务数据对比。点击上方公司名可切换其他公司
Rocket Lab Corp的季度营收约是ARDELYX, INC.的1.9倍（$179.7M vs $94.5M），Rocket Lab Corp净利率更高（-29.5% vs -39.8%，领先10.3%），Rocket Lab Corp同比增速更快（35.7% vs 27.5%），过去两年Rocket Lab Corp的营收复合增速更高（39.2% vs 13.6%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
Rocket Lab是公开上市的航空航天制造商及发射服务提供商，旗下Electron轨道火箭主打小型卫星发射，截至2026年1月已成功完成超75次任务，是全球现役发射次数最多的小型运载火箭。公司还开发了Electron的亚轨道改型HASTE用作高超音速技术测试平台，下一代可复用中型运载火箭Neutron目前也在研发中。
ARDX vs RKLB — 直观对比
营收规模更大
RKLB
是对方的1.9倍
$94.5M
营收增速更快
RKLB
高出8.2%
27.5%
净利率更高
RKLB
高出10.3%
-39.8%
两年增速更快
RKLB
近两年复合增速
13.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $179.7M |
| 净利润 | $-37.6M | $-52.9M |
| 毛利率 | — | 38.0% |
| 营业利润率 | — | -28.4% |
| 净利率 | -39.8% | -29.5% |
| 营收同比 | 27.5% | 35.7% |
| 净利润同比 | — | -1.1% |
| 每股收益（稀释后） | $-0.15 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXRKLB
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $179.7M | ||
| Q3 25 | $110.3M | $155.1M | ||
| Q2 25 | $97.7M | $144.5M | ||
| Q1 25 | $74.1M | $122.6M | ||
| Q4 24 | $116.1M | $132.4M | ||
| Q3 24 | $98.2M | $104.8M | ||
| Q2 24 | $73.2M | $106.3M |
净利润ARDXRKLB
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $-52.9M | ||
| Q3 25 | $-969.0K | $-18.3M | ||
| Q2 25 | $-19.1M | $-66.4M | ||
| Q1 25 | $-41.1M | $-60.6M | ||
| Q4 24 | $4.6M | $-52.3M | ||
| Q3 24 | $-809.0K | $-51.9M | ||
| Q2 24 | $-16.5M | $-41.6M |
毛利率ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 38.0% | ||
| Q3 25 | 96.4% | 37.0% | ||
| Q2 25 | 87.3% | 32.1% | ||
| Q1 25 | 83.4% | 28.8% | ||
| Q4 24 | 84.3% | 27.8% | ||
| Q3 24 | 84.0% | 26.7% | ||
| Q2 24 | 87.1% | 25.6% |
营业利润率ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | -28.4% | ||
| Q3 25 | 4.2% | -38.0% | ||
| Q2 25 | -14.7% | -41.3% | ||
| Q1 25 | -49.0% | -48.3% | ||
| Q4 24 | 7.0% | -38.9% | ||
| Q3 24 | 2.3% | -49.5% | ||
| Q2 24 | -18.6% | -40.7% |
净利率ARDXRKLB
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | -29.5% | ||
| Q3 25 | -0.9% | -11.8% | ||
| Q2 25 | -19.5% | -46.0% | ||
| Q1 25 | -55.5% | -49.5% | ||
| Q4 24 | 4.0% | -39.5% | ||
| Q3 24 | -0.8% | -49.6% | ||
| Q2 24 | -22.5% | -39.2% |
每股收益（稀释后）ARDXRKLB
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $-0.09 | ||
| Q3 25 | $0.00 | $-0.03 | ||
| Q2 25 | $-0.08 | $-0.13 | ||
| Q1 25 | $-0.17 | $-0.12 | ||
| Q4 24 | $0.01 | $-0.11 | ||
| Q3 24 | $0.00 | $-0.10 | ||
| Q2 24 | $-0.07 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $1.0B |
| 总债务越低越好 | $203.5M | $152.4M |
| 股东权益账面价值 | $148.6M | $1.7B |
| 总资产 | $504.5M | $2.3B |
| 负债/权益比越低杠杆越低 | 1.37× | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资ARDXRKLB
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $1.0B | ||
| Q3 25 | $42.7M | $976.7M | ||
| Q2 25 | $90.0M | $688.1M | ||
| Q1 25 | $30.8M | $428.4M | ||
| Q4 24 | $64.9M | $419.0M | ||
| Q3 24 | $47.4M | $442.4M | ||
| Q2 24 | $41.9M | $496.8M |
总债务ARDXRKLB
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | $152.4M | ||
| Q3 25 | $202.1M | $347.0M | ||
| Q2 25 | $201.4M | $346.5M | ||
| Q1 25 | $151.3M | $345.9M | ||
| Q4 24 | $150.9M | $345.4M | ||
| Q3 24 | $100.7M | $61.2M | ||
| Q2 24 | $100.2M | $64.2M |
股东权益ARDXRKLB
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $1.7B | ||
| Q3 25 | $154.3M | $1.3B | ||
| Q2 25 | $139.5M | $688.5M | ||
| Q1 25 | $145.7M | $431.3M | ||
| Q4 24 | $173.3M | $382.5M | ||
| Q3 24 | $158.3M | $419.8M | ||
| Q2 24 | $147.0M | $455.2M |
总资产ARDXRKLB
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $2.3B | ||
| Q3 25 | $486.2M | $2.2B | ||
| Q2 25 | $466.8M | $1.6B | ||
| Q1 25 | $410.2M | $1.3B | ||
| Q4 24 | $435.8M | $1.2B | ||
| Q3 24 | $367.9M | $1.2B | ||
| Q2 24 | $343.5M | $1.2B |
负债/权益比ARDXRKLB
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | 0.09× | ||
| Q3 25 | 1.31× | 0.27× | ||
| Q2 25 | 1.44× | 0.50× | ||
| Q1 25 | 1.04× | 0.80× | ||
| Q4 24 | 0.87× | 0.90× | ||
| Q3 24 | 0.64× | 0.15× | ||
| Q2 24 | 0.68× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-64.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-114.2M |
| 自由现金流率自由现金流/营收 | — | -63.6% |
| 资本支出强度资本支出/营收 | — | 27.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-321.8M |
8季度趋势，按日历期对齐
经营现金流ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $-64.5M | ||
| Q3 25 | $365.0K | $-23.5M | ||
| Q2 25 | $-25.3M | $-23.2M | ||
| Q1 25 | $-38.5M | $-54.2M | ||
| Q4 24 | $9.8M | $-2.4M | ||
| Q3 24 | $501.0K | $-30.9M | ||
| Q2 24 | $-19.4M | $-13.0M |
自由现金流ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $-114.2M | ||
| Q3 25 | $209.0K | $-69.4M | ||
| Q2 25 | $-26.0M | $-55.3M | ||
| Q1 25 | $-38.8M | $-82.9M | ||
| Q4 24 | $9.2M | $-23.9M | ||
| Q3 24 | $364.0K | $-41.9M | ||
| Q2 24 | $-19.5M | $-28.3M |
自由现金流率ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | -63.6% | ||
| Q3 25 | 0.2% | -44.8% | ||
| Q2 25 | -26.6% | -38.3% | ||
| Q1 25 | -52.3% | -67.6% | ||
| Q4 24 | 7.9% | -18.1% | ||
| Q3 24 | 0.4% | -40.0% | ||
| Q2 24 | -26.7% | -26.7% |
资本支出强度ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 27.6% | ||
| Q3 25 | 0.1% | 29.6% | ||
| Q2 25 | 0.7% | 22.2% | ||
| Q1 25 | 0.4% | 23.4% | ||
| Q4 24 | 0.5% | 16.3% | ||
| Q3 24 | 0.1% | 10.5% | ||
| Q2 24 | 0.2% | 14.4% |
现金转化率ARDXRKLB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
RKLB
| Products | $94.0M | 52% |
| Transferred Over Time | $87.3M | 49% |
